Comparison of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections in Pediatric Type 1 Diabetes: A Meta-Analysis and Prospective Cohort Study

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2021 Mar 19

PMID 33737909

Citations 1

Authors

Xu Wang

Xue Zhao

Danrong Chen

Mingzhi Zhang

Wei Gu

Affiliations

Soon will be listed here.

Abstract

Background: The incidence of pediatric type 1 diabetes (T1D) is increasing worldwide, and the appropriate choice of therapy regimens is important for children, especially in developing countries with inadequate resources.

Methods: We conducted a design combining meta-analysis and prospective cohort study. In meta-analysis, 14 studies involving 69,085 TID cases reported glycosylated hemoglobin (HbA) levels, including 48,363 multiple daily insulin injections therapy (MIT) and 20,722 continuous subcutaneous insulin infusion (CSII). In our prospective cohort study, TID cases were recruited from a tertiary children's hospital, and randomly divided into Group MIT and Group CSII. After the 4-year follow-up, the effects of MDI (n = 112) and CSII (n = 76) therapy on glycemic control, long-term complications, as well as the growth and pubertal development were explored.

Results: Compared to CSII in TID, HbA levels in MDI (WMD = 0.21, 95% CI: 0.20 to 0.23) were increased significantly in meta-analysis. Among 188 clinical cases, mean age at recruitment was 7.55 (SD 2.91) years. Duration of TID was 4.23 (SD 2.61) years. 50.53% (n = 95) of them were boys. The 4-year follow-up showed that children's HbA was 0.67 (95% CI -1.28, -0.05) % lower in children with CSII compared to children with MDI in multivariable regression models with adjustment for potential confounders (children's age at follow-up, duration of TID, gender, birthweight, parity, and delivery method). CSII was associated with 2.31 kg higher in children's weight (95% CI 0.59, 4.04) in the adjusted model. No difference was found in peripheral nerve and fundus consequences as well as the status of obesity and thin and pubertal development between CSII and MIT.

Conclusion: CSII might be associated with better glycemic control and better effect for children growth development. No higher risks of long-term complications and delayed pubertal development were observed in CSII. Our findings provided evidence for a better therapy regimen for T1D in children, nevertheless, they need to be validated by a larger sample size study.

Citing Articles

Technologies for Type 1 Diabetes and Contact Dermatitis: Therapeutic Tools and Clinical Outcomes in a Cohort of Pediatric Patients.

Passanisi S, Salzano G, Galletta F, Aramnejad S, Caminiti L, Pajno G Front Endocrinol (Lausanne). 2022; 13:846137.

PMID: 35370980 PMC: 8965381. DOI: 10.3389/fendo.2022.846137.

References

Hanas R, Lindgren F, Lindblad B . A 2-yr national population study of pediatric ketoacidosis in Sweden: predisposing conditions and insulin pump use. Pediatr Diabetes. 2008; 10(1):33-7. DOI: 10.1111/j.1399-5448.2008.00441.x. View

Abaci A, Atas A, Unuvar T, Demir K, Bober E, Buyukgebiz A . A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey. J Pediatr Endocrinol Metab. 2009; 22(6):539-45. DOI: 10.1515/jpem.2009.22.6.539. View

Anderson D . Multiple daily injections in young patients using the ezy-BICC bolus insulin calculation card, compared to mixed insulin and CSII. Pediatr Diabetes. 2008; 10(5):304-9. DOI: 10.1111/j.1399-5448.2008.00484.x. View

Hassan K, Loar R, Anderson B, Heptulla R . The role of socioeconomic status, depression, quality of life, and glycemic control in type 1 diabetes mellitus. J Pediatr. 2006; 149(4):526-31. DOI: 10.1016/j.jpeds.2006.05.039. View

Nabhan Z, Kreher N, Greene D, Eugster E, Kronenberger W, DiMeglio L . A randomized prospective study of insulin pump vs. insulin injection therapy in very young children with type 1 diabetes: 12-month glycemic, BMI, and neurocognitive outcomes. Pediatr Diabetes. 2009; 10(3):202-8. DOI: 10.1111/j.1399-5448.2008.00494.x. View

Mackey E, Rose M, Tully C, Monaghan M, Hamburger S, Herrera N . The current state of parent feeding behavior, child eating behavior, and nutrition intake in young children with type 1 diabetes. Pediatr Diabetes. 2020; 21(5):841-845. DOI: 10.1111/pedi.12997. View

Fendler W, Baranowska A, Mianowska B, Szadkowska A, Mlynarski W . Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1 diabetes. Acta Diabetol. 2011; 49(5):363-70. PMC: 3464376. DOI: 10.1007/s00592-011-0332-7. View

Walter S, Tiemeier H . Variable selection: current practice in epidemiological studies. Eur J Epidemiol. 2009; 24(12):733-6. PMC: 2791468. DOI: 10.1007/s10654-009-9411-2. View

Barili F, Parolari A, Kappetein P, Freemantle N . Statistical Primer: heterogeneity, random- or fixed-effects model analyses?. Interact Cardiovasc Thorac Surg. 2018; 27(3):317-321. DOI: 10.1093/icvts/ivy163. View

10.

Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G . Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics. 2003; 112(3 Pt 1):559-64. DOI: 10.1542/peds.112.3.559. View

11.

Maahs D, Hermann J, Holman N, Foster N, Kapellen T, Allgrove J . Rates of diabetic ketoacidosis: international comparison with 49,859 pediatric patients with type 1 diabetes from England, Wales, the U.S., Austria, and Germany. Diabetes Care. 2015; 38(10):1876-82. DOI: 10.2337/dc15-0780. View

12.

. 12. Children and Adolescents: . Diabetes Care. 2017; 41(Suppl 1):S126-S136. DOI: 10.2337/dc18-S012. View

13.

Weng J, Zhou Z, Guo L, Zhu D, Ji L, Luo X . Incidence of type 1 diabetes in China, 2010-13: population based study. BMJ. 2018; 360:j5295. PMC: 5750780. DOI: 10.1136/bmj.j5295. View

14.

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

15.

Bayrakdar A, Noureddine S, Farhood L, Nasrallah M . Comparison of quality of life in a group of Lebanese type 1 diabetics on insulin pump and those on multiple daily injections. J Med Liban. 2014; 62(1):22-6. DOI: 10.12816/0002623. View

16.

Karges B, Schwandt A, Heidtmann B, Kordonouri O, Binder E, Schierloh U . Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes. JAMA. 2017; 318(14):1358-1366. PMC: 5818842. DOI: 10.1001/jama.2017.13994. View

17.

Marshall W, Tanner J . Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969; 44(235):291-303. PMC: 2020314. DOI: 10.1136/adc.44.235.291. View

18.

Elamin A, Hussein O, Tuvemo T . Growth, puberty, and final height in children with Type 1 diabetes. J Diabetes Complications. 2006; 20(4):252-6. DOI: 10.1016/j.jdiacomp.2005.07.001. View

19.

Perrett K, Jachno K, Nolan T, Harrison L . Association of Rotavirus Vaccination With the Incidence of Type 1 Diabetes in Children. JAMA Pediatr. 2019; 173(3):280-282. PMC: 6439878. DOI: 10.1001/jamapediatrics.2018.4578. View

20.

Skogsberg L, Fors H, Hanas R, Chaplin J, Lindman E, Skogsberg J . Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus. Pediatr Diabetes. 2008; 9(5):472-9. DOI: 10.1111/j.1399-5448.2008.00390.x. View